Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion-Reference-Cited by-同舟云学术

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion

Published:2013-04-24 Issue:9 Volume:18 Page:1060-1070
ISSN:1360-8185
Container-title:Apoptosis
language:en
Short-container-title:Apoptosis

Author:

Wei Wei,Huang He,Zhao Shan,Liu Wei,Liu Chuan-Xu,Chen Li,Li Jun-Min,Wu Ying-Li,Yan Hua

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10495-013-0854-2.pdf

Reference45 articles.

1. Schiffer CA, Hehlmann R, Larson R (2003) Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1). Leukemia 17:691–699

2. Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7:441–453

3. Voss J, Posern G, Hannemann JR et al (2000) The leukaemic oncoproteins Bcr–Abl and Tel–Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways. Oncogene 19:1684–1690

4. Danial NN, Rothman P (2000) JAK-STAT signaling activated by Abl oncogenes. Oncogene 19:2523–2531

5. Kirchner D, Duyster J, Ottmann O, Schmid RM, Bergmann L, Munzert G (2003) Mechanisms of Bcr–Abl-mediated NF-kappaB/Rel activation. Exp Hematol 31:504–511

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway;Biological and Pharmaceutical Bulletin;2024-07-06

2. Sesquiterpene Lactones Containing an α-Methylene-γ-Lactone Moiety Selectively Down-Regulate the Expression of Tumor Necrosis Factor Receptor 1 by Promoting Its Ectodomain Shedding in Human Lung Adenocarcinoma A549 Cells;Molecules;2024-04-19

3. Alantolactone derivatives inhibit the tumor necrosis factor α-induced nuclear factor κB pathway by a different mechanism from alantolactone;European Journal of Pharmacology;2024-04

4. Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis;Frontiers in Pharmacology;2024-03-11

5. Pharmacogenomics in cancer;Pharmacogenomics;2023